Jude A Oben is an expert in Hepatology at St Thomas' Hospital (United Kingdom). Jude A Oben has authored 119 publications, the most recent in 2025, and is an investigator in 4 clinical trials. SLR score: 462 (community average: 125). How the SLR is computed.

LeadR Profile

Jude A Oben St Thomas' Hospital United Kingdom
462 ScienceLeadR Reputation 462
Network Map

Hepatology

Subspecialties: Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Leading healthcare innovation, I am an elected member of SigmaXi - An International Scientific Research Honour Society. More than 200 Nobel Prize winners have been members.https://sigmaxi.org/about. I am a Consultant Gastroenterologist-Hepatologist at Guy's and St Thomas'​ NHS Foundation Trust, with a parallel academic role as a Professor Associate in Experimental Hepatology at King's College London. My expertise in liver diseases, coupled with a steadfast commitment to medical education and research, has positioned me at the forefront of Hepatology and Metabolic Health Disease. My work is driven by a passion to understand and combat liver conditions, which has led to significant contributions in medical research, particularly in the realms of diabetic and obesity-related liver diseases. Collaboratively, my teams have advanced the knowledge of the autonomic nervous system's role in liver repair; trans-generational transmission of obesity and obesity-related liver disease; to influence public health policies and heighten societal awareness about the impact of obesity on health. https://www.linkedin.com/posts/jude-a-oben-md-phd-frcp-agaf-faasld-89a399229_widening-waistbands-are-a-burden-on-britain-activity-7252265316943036417--P4a/?utm_source=share&utm_medium=member_desktop

Organizations

Career arc: 2001 - 2026

Source: PubMed

St Thomas' Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 119

Citations

Citations: 7 270 1st author: 12 Last author: 48 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis.
PMID 40390697 — receptors, angiotensin, crohn disease, fibrosis, losartan, renin, angiotensins, angiotensin receptor antagonists, ileitis, inflammatory bowel diseases, fibroblasts, therapeutics, steroids, renin-angiotensin system
J Crohns Colitis20250
Prevalence of skin fungi markedly declines in the lesions of two patients with moderate hidradenitis suppurativa.
PMID 40473125 — skin, genes, genes, rrna, mycobiome, hidradenitis suppurativa, hidradenitis, prevalence, fungi, wounds and injuries
Microb Pathog20250
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.
PMID 38621924 — cells, acute-on-chronic liver failure, safety, gastroenterology, liver, organoids, cell death
Gut20245
The British Association for the Study of the Liver commitment to equality, diversity, and inclusivity.
PMID 37804849 — gastrointestinal diseases, liver diseases
Lancet Gastroenterol Hepatol Top journal20230
P45 Urinary metabolite biomarkers changes in obesity-induced NAFLD and obesity-induced NAFLD plus XX
OpenAlex W4386886424 — non-alcoholic fatty liver disease, liver, biomarkers, obesity
Poster presentations20230

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 2 1
Phase 3 1

By status:

Completed 2
Terminated 2

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 1
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map